Hamdi L. Doganay
Bahcesehir, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Variant reclassification in cancer susceptibility genes and an updated variant spectrum of Turkish breast and colorectal cancer patients.
Journal: Human genomics
Published: October 17, 2025
Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators.
Journal: Free radical biology & medicine
Published: March 13, 2023
The acute effect of different NAD+ precursors included in the combined metabolic activators.
Journal: Free radical biology & medicine
Published: February 07, 2023
Characteristics of patients with hepatocellular carcinoma: A multicenter study.
Journal: Hepatology forum
Published: August 03, 2022
Immunohistochemical Evaluation of BAP1 Expression in Breast Cancer with Known BRCA1 and BRCA2 Mutations and Comparison with Histopathological Features.
Journal: International journal of surgical pathology
Published: March 09, 2022
A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infection.
Journal: Turkish journal of medical sciences
Published: November 18, 2021
A novel therapeutic approach to NASH: Both polyethylene glycol 3350 and lactulose reduce hepatic inflammation in C57BL/6J mice.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: September 22, 2021
CoronaVac efficacy data from Turkey - Authors' reply.
Journal: Lancet (London, England)
Published: August 27, 2021
Comparison of the Efficacy of Entecavir and Tenofovir in Reducing Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients: A Real-Life Study in Turkey.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: July 07, 2021
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
Journal: Lancet (London, England)
Published: May 18, 2021
Last Updated: 09/26/2026